Tirzepatide Versus Semaglutide and Total Knee Arthroplasty Risk in Adults With Knee Osteoarthritis and Obesity
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.80_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Fady Tawfik und 7 weiteren Autor:innen.
Abstract (Originalsprache)
in the control, pre-DM, and DM groups, respectively.In univariate logistic regression analyses, the crude ORs for IVDD at L5/S1 were 1.71 (95% CI, 1.13-2.60)for the pre-DM group and 3.00 (95% CI, 1.46-6.69)for the DM group, compared with the control group.After adjustment for age, sex, obesity, hypertension, smoking status, and heavy alcohol consumption, DM remained independently associated with IVDD at L5/S1 (adjusted OR, 2.45; 95% CI, 1.09-5.97).Conclusions: DM was highly associated with an increased prevalence of lumbar disc degeneration, particularly at the L5/S1 disc level, in middle-aged adults.These findings suggest that underlying diabetes may contribute to lumbar disc degeneration.
Zitieren
APA
Tawfik, F., Mendoza, M., Maynard, J., Mohamed, K., Ugwuanyi, O., Deverapalli, M., Ononenyi, C., & Michael, M. (2026). Tirzepatide Versus Semaglutide and Total Knee Arthroplasty Risk in Adults With Knee Osteoarthritis and Obesity. PM&R, 18(S3). https://doi.org/10.1002/pmrj.80_70259
Vancouver
Tawfik F, Mendoza M, Maynard J, Mohamed K, Ugwuanyi O, Deverapalli M, et al. Tirzepatide Versus Semaglutide and Total Knee Arthroplasty Risk in Adults With Knee Osteoarthritis and Obesity. PM&R. 2026;18(S3). doi:10.1002/pmrj.80_70259
BibTeX
@article{Tawfik2026,
author = {Tawfik, Fady and Mendoza, Marshall and Maynard, Jesse and Mohamed, Khalid and Ugwuanyi, Ositadimma and Deverapalli, Mrinalini and Ononenyi, Chukwudalu and Michael, Miriam},
title = {Tirzepatide Versus Semaglutide and Total Knee Arthroplasty Risk in Adults With Knee Osteoarthritis and Obesity},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.80_70259}
}
EUVIMED